Rachman Ilya M 4
4 · Immix Biopharma, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
Rachman Ilya M
DirectorCEO and Chairman
Transactions
- Award
Stock Option (Right to Buy)
2025-06-20+340,000→ 340,000 totalExercise: $2.24Exp: 2035-06-20→ Common Stock (340,000 underlying)
Holdings
- 1,138,437
Common Stock
Footnotes (1)
- [F1]The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.